Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
36.46
-0.02 (-0.05%)
Apr 2, 2026, 12:00 PM EDT - Market open

Novo Nordisk Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
163,379227,179384,079466,614308,568258,721
Market Cap Growth
-54.81%-40.85%-17.69%51.22%19.27%57.64%
Enterprise Value
179,534242,783394,917465,978308,911260,197
Last Close Price
36.4650.8886.02103.4667.6756.00
PE Ratio
10.1514.0627.2437.5338.4735.31
PS Ratio
3.364.689.4813.5712.1212.02
PB Ratio
5.367.4519.1929.5725.6823.91
P/TBV Ratio
0.841.172.684.363.683.65
P/FCF Ratio
17.9824.5337.3037.9232.1234.76
P/OCF Ratio
8.7312.1422.7628.9427.1830.76
EV/Sales Ratio
3.705.009.7513.5512.1312.08
EV/EBITDA Ratio
7.4510.3319.2028.1026.1226.31
EV/EBIT Ratio
8.1212.1122.0530.6828.6929.01
EV/FCF Ratio
19.7626.2138.3537.8732.1634.96
Debt / Equity Ratio
0.690.690.770.270.340.41
Debt / EBITDA Ratio
0.890.890.750.250.350.45
Debt / FCF Ratio
2.262.261.500.340.430.59
Net Debt / Equity Ratio
0.510.510.54-0.040.030.14
Net Debt / EBITDA Ratio
0.660.660.53-0.040.030.15
Net Debt / FCF Ratio
1.691.691.05-0.050.040.20
Asset Turnover
0.610.610.740.840.810.83
Inventory Turnover
1.301.301.231.271.291.24
Quick Ratio
0.570.570.570.640.690.67
Current Ratio
0.800.800.740.820.890.86
Return on Equity (ROE)
60.70%60.70%80.78%88.07%72.00%71.24%
Return on Assets (ROA)
19.86%19.86%26.12%29.51%27.60%27.93%
Return on Invested Capital (ROIC)
24.55%24.55%34.33%40.69%37.34%37.38%
Return on Capital Employed (ROCE)
44.36%44.36%65.30%77.37%69.49%69.14%
Earnings Yield
9.86%7.11%3.67%2.66%2.60%2.83%
FCF Yield
5.56%4.08%2.68%2.64%3.11%2.88%
Dividend Yield
3.64%3.59%1.61%1.01%1.19%1.28%
Payout Ratio
36.66%50.53%43.71%37.96%45.57%45.06%
Buyback Yield / Dilution
0.34%0.34%0.71%1.10%1.34%1.58%
Total Shareholder Return
3.98%3.94%2.31%2.11%2.53%2.86%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q